3629 results for «48»

Filter By

3629 results

Multivessel disease or left main disease

22 May 2026 – From EuroPCR 2026

This session explores revascularisation strategies for patients with multivessel or left main coronary artery disease. It emphasizes the role of intravascular physiology and imaging in guiding treatment decisions and highlights procedural factors that contribute to improved long-term clinical outcomes, supported by complex case discussions.

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

21 May 2026 – From EuroPCR 2026

This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

CT and intracoronary imaging evaluation of coronary disease

21 May 2026 – From EuroPCR 2026

This session focuses on advanced imaging modalities for evaluating coronary artery disease, including the clinical application of CT angiography and intracoronary imaging techniques like OCT and IVUS. Topics encompass barriers to OCT usage, the impact of plaque composition on PCI outcomes, advances in photon-counting CT technology,...

Assessing coronaries in ACS with intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session highlights the critical role of intracoronary imaging in evaluating acute coronary syndromes (ACS). It discusses the management of complex lesion morphologies involving calcium and thrombus, the diagnostic power of OCT in decision-making, challenges beyond angiography in right coronary artery pathology, and the identification of...

Challenges of multivessel disease in ACS

21 May 2026 – From EuroPCR 2026

Dedicated to the challenges of multivessel disease in acute coronary syndrome (ACS), this session explores strategies to identify culprit versus non-culprit lesions and plan multivessel revascularisation using physiology, intravascular imaging, and artificial intelligence. It further discusses the timing considerations for revascularisation, whether ad-hoc or staged, illustrated...

Challenges of multivessel disease in ACS

New data on intracoronary imaging-guided interventions

21 May 2026 – From EuroPCR 2026

This session presents new data on intracoronary imaging-guided interventions, comparing outcomes of angiography-derived FFR and IVUS-guided PCI over two years, as well as OCT versus IVUS for intermediate left main stenosis. It further evaluates high-risk non-culprit lesions post-myocardial infarction, the role of coronary lipid burden in...

New data on intracoronary imaging-guided interventions

Case-based challenges and dilemmas in multivessel PCI

21 May 2026 – From EuroPCR 2026

This session addresses real-world challenges in multivessel PCI for stable and acute coronary syndromes, emphasizing decision-making, procedure planning, and complication management. It highlights the application of imaging, physiology, and contemporary tools such as DCB to optimize outcomes through illustrative cases from Bangladesh, Brunei Darussalam, and the...

Advancing mitral transcatheter edge-to-edge repair in complex lesions

20 May 2026 – From EuroPCR 2026

Learn how advanced imaging, careful anatomical assessment and tailored procedural strategies are helping expand the possibilities of mitral transcatheter edge-to-edge repair (M-TEER) in complex lesions.

Focusing on atrial secondary mitral regurgitation (SMR) and commissural mitral regurgitation, this EuroPCR 2026 session reviews evidence, showing that M-TEER can be...

Advancing mitral transcatheter edge-to-edge repair in complex lesions

How should I treat a patient with a calcified mitral anatomy?

19 May 2026 – From EuroPCR 2026

This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.

How should I treat a patient with a calcified mitral anatomy?
Didn’t find what you were looking for?